Earnings Feed
Start Free
Home/Filings/4/0001077183-22-000110
4//SEC Filing

HANNAH ALISON L. 4

Accession 0001077183-22-000110

CIK 0001077183other
View on SEC.govCompany Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 8:42 PM ET

Size

15.0 KB

Accession

0001077183-22-000110

Insider Transaction Report

Form 4
Period: 2022-06-10
NEOGENOMICS INCNEO
HANNAH ALISON L.
Director
Transactions
  • Award

    Common Stock

    2022-06-10+15,556→ 107,433 total
  • Award

    Stock Option (Right to Buy)

    2022-06-10+13,882→ 13,882 total
    Exercise: $8.10From: 2023-06-10Exp: 2029-06-10→ Common Stock (13,882 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
    3,448

  • Stock Option (Right to Buy)

    Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying)
    3,017

  • Stock Option (Right to Buy)

    Exercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying)
    3,714

  • Stock Option (Right to Buy)

    Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
    4,269

Documents

2 files

Issuer

NEOGENOMICS INC

CIK 0001077183

→
Entity typeother

Related Parties

1
  • filerCIK 0001645600

Filing Metadata

Form type
4
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 8:42 PM ET
Size
15.0 KB
View on SEC.gov